JPMorgan Chase & Co’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.8K | Sell |
5,447
-1,203,177
| -100% | -$397K | ﹤0.01% | 5666 |
|
|
2025
Q1 | $377K | Sell |
1,208,624
-209,682
| -15% | -$65.4K | ﹤0.01% | 4168 |
|
|
2024
Q4 | $1.32M | Sell |
1,418,306
-45,532
| -3% | -$42.5K | ﹤0.01% | 3631 |
|
|
2024
Q3 | $1.73M | Sell |
1,463,838
-2,595
| -0.2% | -$3.06K | ﹤0.01% | 3349 |
|
|
2024
Q2 | $1.13M | Sell |
1,466,433
-111,628
| -7% | -$85.9K | ﹤0.01% | 3438 |
|
|
2024
Q1 | $4.81M | Sell |
1,578,061
-53,681
| -3% | -$164K | ﹤0.01% | 2608 |
|
|
2023
Q4 | $5.25M | Buy |
1,631,742
+18,333
| +1% | +$59K | ﹤0.01% | 2532 |
|
|
2023
Q3 | $6.2M | Buy |
1,613,409
+1,565,762
| +3,286% | +$6.01M | ﹤0.01% | 2297 |
|
|
2023
Q2 | $156K | Buy |
47,647
+45,791
| +2,467% | +$150K | ﹤0.01% | 4414 |
|
|
2023
Q1 | $5K | Hold |
1,856
| – | – | ﹤0.01% | 5390 |
|
|
2022
Q4 | $4K | Sell |
1,856
-2,609
| -58% | -$5.62K | ﹤0.01% | 5268 |
|
|
2022
Q3 | $8K | Buy |
4,465
+1,427
| +47% | +$2.56K | ﹤0.01% | 5106 |
|
|
2022
Q2 | $7K | Sell |
3,038
-5,009
| -62% | -$11.5K | ﹤0.01% | 5245 |
|
|
2022
Q1 | $25K | Buy |
8,047
+1,934
| +32% | +$6.01K | ﹤0.01% | 5224 |
|
|
2021
Q4 | $20K | Buy |
6,113
+1,231
| +25% | +$4.03K | ﹤0.01% | 5331 |
|
|
2021
Q3 | $16K | Buy |
4,882
+1,634
| +50% | +$5.36K | ﹤0.01% | 5175 |
|
|
2021
Q2 | $13K | Sell |
3,248
-14,680
| -82% | -$58.8K | ﹤0.01% | 5180 |
|
|
2021
Q1 | $72K | Sell |
17,928
-3,136
| -15% | -$12.6K | ﹤0.01% | 4727 |
|
|
2020
Q4 | $49K | Buy |
21,064
+5,104
| +32% | +$11.9K | ﹤0.01% | 4450 |
|
|
2020
Q3 | $95K | Sell |
15,960
-8,356
| -34% | -$49.7K | ﹤0.01% | 4070 |
|
|
2020
Q2 | $179K | Sell |
24,316
-60,537
| -71% | -$446K | ﹤0.01% | 3717 |
|
|
2020
Q1 | $253K | Sell |
84,853
-134,876
| -61% | -$402K | ﹤0.01% | 3610 |
|
|
2019
Q4 | $912K | Buy |
219,729
+122,336
| +126% | +$508K | ﹤0.01% | 3139 |
|
|
2019
Q3 | $316K | Buy |
97,393
+27,167
| +39% | +$88.1K | ﹤0.01% | 3537 |
|
|
2019
Q2 | $129K | Sell |
70,226
-23,865
| -25% | -$43.8K | ﹤0.01% | 3926 |
|
|
2019
Q1 | $167K | Sell |
94,091
-40,236
| -30% | -$71.4K | ﹤0.01% | 3833 |
|
|
2018
Q4 | $325K | Buy |
134,327
+79,495
| +145% | +$192K | ﹤0.01% | 3582 |
|
|
2018
Q3 | $311K | Buy |
54,832
+31,687
| +137% | +$180K | ﹤0.01% | 3703 |
|
|
2018
Q2 | $181K | Sell |
23,145
-9,861
| -30% | -$77.1K | ﹤0.01% | 3858 |
|
|
2018
Q1 | $233K | Buy |
33,006
+27,343
| +483% | +$193K | ﹤0.01% | 3670 |
|
|
2017
Q4 | $56K | Buy |
+5,663
| New | +$56K | ﹤0.01% | 4094 |
|